• Product search
Suggested search terms
  • test
  • Current
  • 2010'
  • 2000'
  • 1990'
  • ~1980'

Great leap into the global market

  • 2022

    Atomega launced in KR

  • 2020

    Selected as a regional economy-leading company for the youth recruitment support project.

    Establishment of Kuhnil Bio Pharm

    Certified as an innovative workplace company.

    Obtained approval of Rosumega for Europe and Mongolia

Growing into a global pharmaceutical company

  • 2019

    Approval of EU-GMP

  • 2018

    Signed an export contract with S.P.A Corp., Italy (exporting indigenously developed Rosumega soft capsules for hyperlipidemia treatment).

    KI1106 selected as a government-supporting project.

  • 2017

    Signed an exclusive contract with Kitov Corp., Israel (for a complex for the treatment of osteoarthritis).

    Completion of the 2nd GMP-based plant in Cheonan

    Establishment of BrioPharma, our subsidiary

    Launching of Rosumega (Rosuvastatin plus omega-3).

  • 2016

    Signed the technical alliance with Neurim Corp., Israel (to introduce Slenyto which is under development as the world's first pediatric sleep disorder treatment).

  • 2012

    Signed the technical alliance contract with Neurim Corp., Israel

    (Launched Circadin, the first in Korea and the world's only sleep hormone-based treatment for insomnia)

    Selected as an innovative pharmaceutical company.

    Establishment of STH Pharm, our subsidiary.

  • 2011

    Integration of the R&D Unit and the Head Office through relocation to Jeong-dong.

  • 2010

    Relocation of the Head Office to Jeong-dong.

Ceaseless R&D for market leadership

  • 2009

    Secured the investment from TTY Corp., Taiwan.

    Establishment of Ohsong Pharm, our subsidiary.

  • 2008

    Signed a technical alliance with Emcure Corp., India.

  • 2007

    Signed a technical alliance with TTY Biotech Corp., Taiwan.

  • 2006

    Signed a technical alliance with BioSyntech Corp., USA.

  • 2005

    Signed a technical alliance with YM Biosyntech Corp., Canada.

    Signed a technical alliance with BioPro(Guilford) Corp., USA.

    Signed a technical alliance with Regulon Corp., Greece.

    Signed a technical alliance with Cubist Corp., USA.

    Signed a Korean license agreement for Multiferon® with Viragen Corp., USA.

  • 2004

    Signed a technical alliance with Novatis (Gerber) Corp., Switzerland.

    Signed a technical alliance with Vita Corp. and Vinas Corp., Spain.

    Signed a technical alliance with SMB Corp. and Ipr@d Corp., France.

    Signed a technical alliance with Senju (Bronuck®) Corp., Japan.

    Signed a technical alliance with Pronova (Omacor®) Corp., Norway.

  • 2003

    Signed a technical alliance with King Pharmaceuticals Corp., USA.

    Certified as KGMP (Excellent Pharmaceutical Manufacturing and Quality Control Standard) qualified company.

  • 2002

    Signed a technical alliance with Bausch & Lom Corp., USA (for ophthalmic products including Ocubyte).

    Establishment of Penmix Co., Ltd., a subsidiary specializied in penicillin production.

    CEO Young-Joong Kim was inaugurated.

  • 2001

    Signed a technical alliance with Tedec Meiji Corp., Spain.

R&D through technical alliance

  • 1998

    Signed a technical alliance with Biocodex Corp., France (A new level of yeast intestinal agent Biople launched).

  • 1997

    Changed the company name from Kuhnil Yakpum to Kuhnil Pharm.

    Extension of the Kuhnil Central R&D Center.

  • 1994

    Signed a technical alliance with Solco Basel AG Corp., Switzerland (for Solcosfrene, a treatment for menopause disorders).

  • 1992

    Signed a technical alliance with Lek dd Ljubljana (Sandoz) Corp., Slovenia.

    (Amocla, a broad spectrum antibiotic effective against resistant bacteria, launched)

    Approval of the Kuhnil Central R&D Center(Jiksan-eup, Cheonan-si, Chungnam).

  • 1991

    Signed a technical alliance with Schering-Plough Corp., USA.

  • 1990

    Designated as a KGMP-qualified company (Jiksan-eup, Cheonan-si, Chungnam).

Having a start to create a healthy life

  • 1986

    Signed a technical alliance with Parke-Davis Corp., USA.

    Signed a technical alliance with Wyeth-Ayerst International Inc., USA (A arthritis treatment Lodine released).

    Signed a technical alliance with Merrell Dow Corp., USA.

  • 1979

    Signed a technical alliance with Merck Corp.

  • 1969

    Establishment of Kuhnil Pharm. (in Busan).

    CEO Yong-Ok Kim was inaugurated.